Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant

• Status: Terminated
• Trial end date: 2015-10-15
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine whether cinacalcet, used in patients with secondary hyperparathyroidism to control excessive parathyroid hormone, can normalize low blood phosphorus that is commonly seen in patients who have had a kidney transplant.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Montefiore Medical Center
• Treatments: Cinacalcet; Cinacalcet Hydrochloride

Criteria

Inclusion Criteria:

• renal transplant within last 3 months

• serum phosphorus less than 2.0 mg/dl

• serum creatinine less than 2.0 mg/dl

Exclusion Criteria:

• sensitivity to cinacalcet

• use of amitryptiline, desipramine, itraconazole, ketoconazole

• pregnancy